[Trans-membrane peptide therapy for malignant glioma by use of a peptide derived from the MDM2 binding site of p53.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE